The Effect of Laughter Yoga on Symptom Severity, Depression-anxiety-stress, Sleep Quality and Quality of Life in Patients with Irritable Bowel Syndrome
Recruiting · NCT06705153 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
laughter yoga
What this trial is about
The study will be conducted to evaluate the effect of laughter yoga on symptom severity, depression, anxiety, stress, sleep and quality of life in patients with Irritable Bowel Syndrome (IBS). The following hypotheses will be tested in this study: H1: Laughter yoga reduces symptom severity in patients with IBS. H2: Laughter yoga reduces depression, anxiety and stress in patients with IBS. H3: Laughter yoga improves sleep quality in patients with IBS. H4: Laughter yoga improves quality of life in patients with IBS.
Who can take part
Age range
18 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosed with IBS according to Rome IV criteria,
- Scoring 75 and above on the IBS-SSS score,
- DASS-42 scores of 10 and above for depression, 8 and above for anxiety, 15 and above for stress,
- Over 18 years of age,
- Bleeding hemorrhoids, all types of hernia, persistent cough, severe back pain, heart diseases, high blood pressure, urinary incontinence, major psychiatric diseases, pregnancy, cold/flu, no epilepsy, no surgery in the last three months, etc.
- Patients with a smartphone/computer where it is possible to participate in a video call for laughter yoga,
- Patients without communication problems and
- Patients who agree to participate in the study will be included in the study.
Exclusion criteria
- who do not practice laughter yoga,
- who do not attend regularly,
- Patients whose treatment regimen has changed and
- Patients who wish to leave the study will be excluded from the study.
Where it is running
2 locations listed.
- Erzurum City Hospital - Erzurum, Yakutiye, Turkey (Türkiye)
- Erzurum City Hospital - Erzurum, Yakutiye, Turkey (Türkiye)